Tracing the In-Utero Path of a Rare Cancer Between Identical Twins

Researchers analyzed 45 tumor, tissue, and placental samples to reconstruct the timeline of this rare pathology. While both infants carried the same MN1-ZNF341 gene fusion, genetic markers unique to each twin confirmed that the malignancy originated in one child before migrating to the other. Evidence suggests the tumor took hold late in the first trimester, with the cross-placental transfer occurring during the second.

Beyond the cancer's spread, the study revealed a high degree of cellular exchange between the siblings. Analysis of a spleen sample showed that roughly 75% of its cells originated from the other twin, indicating a significant cross-circulation of blood cells. The research, published in Nature Communications, suggests the embryos may have separated earlier than traditional models of identical twinning predict. While this case is unique, it provides a rare, albeit somber, window into fetal development and the potential for disease transmission before birth.